ReviewThe Lancet. Oncology2010
Collateral damage: toxic effects of targeted antiangiogenic therapies in ovarian cancer.
Rebecca L Stone et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this paperpooled ittrialcites it